Table 3 Cognitive and symptom outcomes in parallel groups analyses

From: Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia

Omnibus tests for measure x treatment x visit interaction

(M)ANOVA results

Placebo LSD comparisons

Raloxifene LSD comparisons

Measure

N

Test value

F-test

P-value

Mean difference (s.e.)

P-value

Cohen's d

Mean difference (s.e.)

P-value

Cohen's d

Cognitive outcomes

 Cognitive tests: condition × time

79

W-L 0.9

(4,74)=2.7

0.04

      

WAIS-III-LNS

79

H-F 0.4

(1,78)=1.9

0.17

−0.2 (0.1)

0.03

0.23

−0.0 (0.1)

0.80

0.03

WMSR-LMI

79

H-F 2.2

(1,78)=4.2

0.04

−0.3 (0.2)

0.07

0.26

−0.8 (0.2)

<0.001a

0.64

WMSR-LMII

79

H-F 1.4

(1,78)=2.2

0.14

−0.3 (0.2)

0.07

0.30

−0.7 (0.2)

<0.001a

0.62

COWAT

79

H-F 1.1

(1,78)=4.6

0.03

0.2 (0.1)

0.08

0.21

−0.1 (0.1)

0.21

0.14

 TMT-A: condition × time

57

W-L 0.9

(1,55)=6.0

0.02

      

TMT-A

    

0.1 (0.2)

0.77

0.05

0.7 (0.2)

<0.001a

0.59

Symptom outcomes

 PANSS tests: condition × time

79

W-L 1.0

(3,75)=0.7

0.54

      

Positive

 

−

−

−

1.2 (0.4)

<0.01

0.27

0.8 (0.4)

0.05

0.16

Negative

 

−

−

−

−0.0 (0.6)

0.96

0.00

0.9 (0.5)

0.11

0.17

General

 

−

−

−

1.8 (0.7)

0.01

0.22

2.0 (0.7)

<0.01

0.23

 DASS tests: condition × time

78

W-L 1.0

(3,74)=1.1

0.35

      

Depression

 

−

−

−

1.1 (1.3)

0.39

0.11

2.9 (1.3)

0.03

0.34

Anxiety

 

−

−

−

0.8 (1.1)

0.47

0.11

1.3 (1.1)

0.24

0.21

Stress

 

−

−

−

2.2 (1.4)

0.11

0.24

0.9 (1.4)

0.52

0.11

SF-36v2 total: condition × time

77

W-L 1.0

(1,75)=0.0

0.84

−4.9 (2.1)

0.02

0.27

−4.3 (2.1)

0.04

0.24

SQLS total: condition × time

75

W-L 1.0

(1,73)=0.1

0.81

4.3 (2.2)

0.05

0.25

5.1 (2.1)

0.02

0.31

  1. Abbreviations: COWAT, Controlled Oral Word Association Test; DASS, depression anxiety and stress scale; H-F, Huynh-Feldt value; LSD, least significant difference; PANSS, positive and negative syndrome scale; SF-36v2, short form 36 version 2 health survey questionnaire; SQLS, Schizophrenia Quality of Life Scale; TMT-A, Trail Making Test A; W-L, Wilk's Lamda; WAIS-III-LNS, Wechsler Adult Intelligence scale 3rd Edition letter number sequencing; WMSR-LMI, Wechsler Memory Scale Revised Logical Memory I; WMSR-LMII, Wechsler Memory Scale Revised Logical Memory II.
  2. aSignificant after Holm–Bonferroni correction.
  3. Cohen's d calculated as (mean difference)/(s.d. pooled). Cognitive z-scores were used for cognitive analyses.
  4. Mean difference reflects the change from baseline to 6 weeks for each condition, where a negative value is an improvement for LNS, LMI, LMII, COWAT and SF-36v2 and a positive value is an improvement for TMT-A, PANSS positive, negative, general, DASS depression, anxiety, stress and SQLS total.